Preparation and in vitro evaluation of solid dispersions of halofantrine

被引:51
作者
Abdul-Fattah, AM [1 ]
Bhargava, HN [1 ]
机构
[1] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Boston, MA 02115 USA
关键词
halofantrine; solid dispersion; PEG; 8000; PVP k30; Gelucire (R) 44/14; sodium taurocholate; dissolution rate;
D O I
10.1016/S0378-5173(01)00941-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The low aqueous Solubility of halofantrine (HF) and its low bioavailability from commercially available tablets (Halfan(R)) suggested the formulation of solid dispersions (SDs) of HF to reduce its particle size and improve its wettability and aqueous solubility. Preformulation studies involved the development of a high performance liquid chromatography (HPLC) method for the analysis of HF. In addition, solubility studies were conducted on HF in aqueous solutions containing different concentrations of various carriers. Formulation studies included the preparation of SDs and physical mixtures (PMs) of HF with different carriers and their physicochemical characterization using differential scanning calorimetry (DSC), Fourier-Transform infra-red (FT-IR) spectroscopy and dissolution studies. A 3-month stability Study at elevated temperatures was conducted on representative SDs of HF with selected carriers. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:17 / 33
页数:17
相关论文
共 17 条
[1]  
Ajayi F. O., 1994, Clinical Research and Regulatory Affairs, V11, P193, DOI 10.3109/10601339409035942
[2]   Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques [J].
Betageri, GV ;
Makarla, KR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 126 (1-2) :155-160
[3]  
BOYLAN JC, 1986, THEORY PRACTICE IND
[4]  
Charman W. N., 1997, B TECHNIQUE GATTEFOS, V90, P27
[5]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[6]  
FLAHARTY K, 1998, PHARMACOL RES S, V10, pS298
[7]  
*GATT, 1999, GATT B, P3
[8]   A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine [J].
Humberstone, AJ ;
Porter, CJH ;
Charman, WN .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (05) :525-529
[9]   AN IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS MEASUREMENT OF HALOFANTRINE AND DESBUTYLHALOFANTRINE IN HUMAN SERUM [J].
KEERATITHAKUL, D ;
TEJAISAVADHARM, P ;
SHANKS, GD ;
WEBSTER, HK ;
EDSTEIN, MD .
THERAPEUTIC DRUG MONITORING, 1991, 13 (01) :64-68
[10]   Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine [J].
Khoo, SM ;
Humberstone, AJ ;
Porter, CJH ;
Edwards, GA ;
Charman, WN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 167 (1-2) :155-164